ScholarIQanswers from OpenAlex

CD13 is a therapeutic target in human liver cancer stem cells

PaperCitations, authors & open-access status

CD13 is a therapeutic target in human liver cancer stem cells is a paper indexed in ScholarIQ from OpenAlex.

How many citations does CD13 is a therapeutic target in human liver cancer stem cells have?

ScholarIQcitation count

CD13 is a therapeutic target in human liver cancer stem cells has 606 citations in the OpenAlex counts ScholarIQ stores.

When was CD13 is a therapeutic target in human liver cancer stem cells published?

ScholarIQyear

CD13 is a therapeutic target in human liver cancer stem cells has 2010 year in the ScholarIQ index.

What is the open-access status of CD13 is a therapeutic target in human liver cancer stem cells?

ScholarIQoa status

CD13 is a therapeutic target in human liver cancer stem cells has bronze oa status in the ScholarIQ index.

What is the DOI of CD13 is a therapeutic target in human liver cancer stem cells?

ScholarIQdoi

The DOI for CD13 is a therapeutic target in human liver cancer stem cells is on the source record.

What is the PMID of CD13 is a therapeutic target in human liver cancer stem cells?

ScholarIQpmid

The PMID for CD13 is a therapeutic target in human liver cancer stem cells is on the source record.

What is the OpenAlex record for CD13 is a therapeutic target in human liver cancer stem cells?

ScholarIQopenalex

The OpenAlex for CD13 is a therapeutic target in human liver cancer stem cells is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial